BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4743066)

  • 1. A study on the monitoring of gonadotrophin therapy by the assay of plasma oestradiol and progesterone.
    Shaaban MM; Klopper A
    J Obstet Gynaecol Br Commonw; 1973 Sep; 80(9):783-93. PubMed ID: 4743066
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Plasma oestradiol and progesterone estimations in the monitoring of the induction of ovulation by human menopausal gonadotrophin and human chorionic gonadotrophin.
    McGarrigle HH; Radwanska E; Little V; Swyer GI
    J Endocrinol; 1974 May; 61(2):LXXXI-LXXXII. PubMed ID: 4835931
    [No Abstract]   [Full Text] [Related]  

  • 3. The monitoring of gonadotrophin therapy by plasma oestradiol and progesterone determinations.
    McGarrigle HH; Radwanska E; Little V; Swyer GI
    J Obstet Gynaecol Br Commonw; 1974 Sep; 81(9):657-66. PubMed ID: 4416367
    [No Abstract]   [Full Text] [Related]  

  • 4. An assessment of urinary and plasma steroid estimations for monitoring treatment of anovulation with gonadotrophins.
    Black WP; Coutts JR; Dodson KS; Rao LG
    J Obstet Gynaecol Br Commonw; 1974 Sep; 81(9):667-75. PubMed ID: 4411958
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of different doses of human chorionic gonadotrophin in the treatment of anovulation with human gonadotrophins.
    Starup J; Sele V
    Acta Endocrinol (Copenh); 1972 Nov; 71(3):469-79. PubMed ID: 4678196
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of primary amenorrhoea with human pituitary and chorionic gonadotrophins.
    Gemzell C; Carlborl ; Johansson ED; Roos P
    J Obstet Gynaecol Br Commonw; 1970 Jan; 77(1):58-64. PubMed ID: 5419871
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of secondary amenorrhea 2nd grade with interesting clinical features (author's transl)].
    Kusuda M; Kumamoto H; Nagata Y; Kurano A; Nakamura M
    Nihon Funin Gakkai Zasshi; 1974 Jul; 19(3):33-40. PubMed ID: 4478820
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of anovulation with human menopausal gonadotrophin.
    Freedman RS; van der Walt LA
    S Afr Med J; 1976 Mar; 50(13):519-22. PubMed ID: 1265551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of urinary estrone and other parameters in monitoring gonadotropin therapy.
    Shahani SM; Natarajan PG; Merchant PC
    J Obstet Gynaecol India; 1975 Oct; 25(5):675-82. PubMed ID: 1228031
    [No Abstract]   [Full Text] [Related]  

  • 10. The site of secretion of androstenedione in non-pregnant women.
    Baird DT; Burger PE; Heavon-Jones GD; Scaramuzzi RJ
    J Endocrinol; 1974 Oct; 63(1):201-12. PubMed ID: 4424206
    [No Abstract]   [Full Text] [Related]  

  • 11. [Induction of ovulation with human gonadotropins. Our experience in 24 cases].
    Alvarez Bravo A; Murillo Delgado J; Vázquez E; Valencia Madera I
    Ginecol Obstet Mex; 1973 Jun; 33(200):579-85. PubMed ID: 4732313
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-ovulatory plasma levels of 17beta-oestradiol (E2) and conception in patients treated with gonadotrophins.
    Ferin J; Thomas K; De Hertogh R
    Acta Endocrinol Suppl (Copenh); 1977; 214():33-42. PubMed ID: 268747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma oestradiol and progesterone estimation for the monitoring of induction of ovulation with clomiphene and chorionic gonadotrophin.
    Swyer GI; Radwanska E; Mcgarrigle HH
    Br J Obstet Gynaecol; 1975 Oct; 82(10):794-804. PubMed ID: 1191588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of 2 methods for monitoring gonadotrophin therapy.
    Sallam HN; Bashmi YA
    Aust N Z J Obstet Gynaecol; 1989 May; 29(2):160-4. PubMed ID: 2508610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corpus luteum function in ovulation stimulation with Pergonal].
    Pakhomova IA; Fanchenko ND
    Akush Ginekol (Mosk); 1983 Nov; (11):33-6. PubMed ID: 6421191
    [No Abstract]   [Full Text] [Related]  

  • 16. Ovarian receptivity to human gonadotropins in primary selective pituitary deficiency in gonadotropins.
    Van Campenhout J; Borreman E
    Int J Fertil; 1972; 17(2):97-103. PubMed ID: 4362135
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between plasma estradiol and estrone-3-glucuronide in urine during the monitoring of ovarian induction therapy.
    Catalan R; Castellanos JM; Palomino T; Senti M; Antolin M; Galard RM
    Int J Fertil; 1989; 34(4):271-5. PubMed ID: 2570765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of ovulation with human gonadotropins, analysis of plasma steroid pattern.
    Bettendorf G; Lehmann F; Breckwoldt M
    Endocrinol Exp; 1973 Sep; 7(3):215-20. PubMed ID: 4543019
    [No Abstract]   [Full Text] [Related]  

  • 19. Androstenedione, 17 beta-estradiol and progesterone plasma levels in gonadotropins induction of ovulation.
    Scirpa P; Mango D; Montemurro A; Battaglia F; Cantafio L
    J Endocrinol Invest; 1984 Aug; 7(4):357-62. PubMed ID: 6438220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of treatments of infertile women with defective luteal phases by human menopausal gonadotrophin and human chorionic gonadotrophin.
    Cooke ID
    J Reprod Fertil; 1973 May; 33(2):355. PubMed ID: 4707338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.